Plunkett Research Online: BioMerieux SA

BIOMERIEUX SA (BMXXY:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about.....



BioMerieux SA
Ticker: BMXXY
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 478872000
Fax: 33 478872090
Address: Marcy l’Etoile
Lyon, 69280 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Diagnostic Reagents Merchant Wholesalers
Biotechnology
Diagnostic Solutions
Reagents
Diagnostic Instruments
Software
Contacts Description
Alexandre MerieuxCEO/Chairman of the Board/Director
Marie-Paule KienyDirector
See More
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about.....See More See More

Auditor: Grant Thornton
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
AIR IDEAL
BACT/ALERT
BIOBALL
CONNECT-UP
CULTURE MEDIA
DILUMAT
eGENE-UP
ENDOEXT
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: